Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Iris Isufi"'
Autor:
Rory M. Shallis, Stuart Seropian, Amer M. Zeidan, Nikolai A. Podoltsev, Steven D. Gore, Lohith Gowda, Karl Hager, Tae Kon Kim, Jan Philipp Bewersdorf, Iris Isufi, Alexa J. Siddon, Manoj M. Pillai, Wei Wei
Publikováno v:
Leuk Lymphoma
Mutations in the tumor suppressor gene TP53 are detected in 5–10% of patients with acute myeloid leukemia (AML) and myelodysplastic syndromes. TP53 mutations have been associated with complex karyotypes, therapy-related malignancies, lower response
Publikováno v:
Leuk Lymphoma
A recent phase II trial showed that use of polatuzumab vedotin in combination with bendamustine plus rituximab (Pola-BR) in transplant-ineligible patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) resulted in longer prog
Autor:
Michael Girardi, Lynn D. Wilson, Stuart Seropian, Francine M. Foss, Sarah Perreault, Kenneth B. Roberts, Lohith Gowda, Iris Isufi
Publikováno v:
Leukemialymphoma. 61(12)
We report results on 23 patients with cutaneous T cell lymphoma (7 primary cutaneous γδ T cell lymphoma [PCGDT], 16 mycosis fungoides/Sézary syndrome [MF/SS]) who underwent allogeneic stem cell transplantation. All pts had skin involvement, 14 had
Autor:
Kathryn Pratt, Stuart Seropian, Iris Isufi, Sarah Perreault, Francine M. Foss, Erin Medoff, Dennis L. Cooper, Julie Baker
Publikováno v:
Supportive Care in Cancer. 25:205-208
Purpose Carmustine (BCNU) is used in the conditioning regimens BEAM and CBV for autologous stem cell transplantation. Carmustine-related infusion reactions, while not described in the BEAM literature, occurred in 95 % of patients who received CBV. Th
Publikováno v:
Bone marrow transplantation. 51(2)
After allogeneic stem cell transplant, severe grade III-IV gastrointestinal (GI) acute GvHD is associated with significant morbidity and mortality, and generally results in poor outcomes. Salvage therapy for patients who fail steroid therapy is not w
Autor:
Craig Okada, Christopher R. Flowers, Hailing Lu, Elizabeth Cull, Ian Chau, Kim Linton, Weiyun Z. Ai, Luis Merino, Locke J. Bryan, Alex F. Herrera, Bela Kis, Iris Isufi, Ahmad Halwani, Frank J. Hsu, Nancy L. Bartlett, Carlos Panizo, Javier Briones, Roch Houot, Gottfried von Keudell, Jorge Chaves
Publikováno v:
Journal of Clinical Oncology. 35:7537-7537
7537 Background: Follicular lymphoma (FL) is an incurable malignancy with patients (pts) ultimately relapsing following standard therapies. Active immunotherapy has the potential to induce life-long host anti-tumor immunity and disease control. G100